In the latest trading session, 6.22 million P3 Health Partners Inc (NASDAQ:PIII) shares changed hands as the company’s beta touched 0.93. With the company’s most recent per share price at $0.15 changed hands at -$0.02 or -9.78% at last look, the market valuation stands at $55.50M. PIII’s current price is a discount, trading about -646.67% off its 52-week high of $1.12. The share price had its 52-week low at $0.16, which suggests the last value was -6.67% down since then. When we look at P3 Health Partners Inc’s average trading volume, we note the 10-day average is 0.38 million shares, with the 3-month average coming to 2.44 million.
Analysts gave the P3 Health Partners Inc (PIII) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended PIII as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. P3 Health Partners Inc’s EPS for the current quarter is expected to be 0.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Instantly PIII was in red as seen in intraday trades today. With action -15.82%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -31.28%, with the 5-day performance at -15.82% in the red. However, in the 30-day time frame, P3 Health Partners Inc (NASDAQ:PIII) is -32.80% down. Looking at the short shares, we see there were 1.7 million shares sold at short interest cover period of 1.4 days.
P3 Health Partners Inc (PIII) estimates and forecasts
Year-over-year growth is forecast to reach 19.13% up from the last financial year. Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 378.88M. 1 analysts are of the opinion that P3 Health Partners Inc’s revenue for the current quarter will be 375.8M. The company’s revenue for the corresponding quarters a year ago was 346.86M and 388.49M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.23%. The estimates for the next quarter sales put growth at -3.27%.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 62.08% of P3 Health Partners Inc shares while 13.27% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 35.00%. There are 13.27% institutions holding the P3 Health Partners Inc stock share, with ALYESKA INVESTMENT GROUP, L.P. the top institutional holder. As of 2024-06-30, the company held 11.6756% of the shares, roughly 15.95 million PIII shares worth $7.18 million.
ARMISTICE CAPITAL, LLC holds the second largest percentage of outstanding shares, with 5.7833% or 7.9 million shares worth $3.56 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund. With 1.45 shares estimated at $0.23 million under it, the former controlled 0.89% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.29% of the shares, roughly 469.71 shares worth around $74261.0.
